1-14 of 14
Leslie J Klaff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

236-OR: Volagidemab, a Human Glucagon Receptor Antagonist, Improves Glycemic Control in Subjects with Type 1 Diabetes (T1D): A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

JEREMY PETTUS, SCHAFER C. BOEDER, MARK P. CHRISTIANSEN, DOUGLAS S. DENHAM, TIMOTHY S. BAILEY, HALIS K. AKTURK, LESLIE J. KLAFF, JULIO ROSENSTOCK, MICKIE H.M. CHENG, BRUCE W. BODE, EDGAR D. BAUTISTA, HAI YAN, DUNG THAI, SATISH K. GARG, SAMUEL KLEIN
Journal: Diabetes
Diabetes 2021;70(Supplement_1):236-OR
https://doi.org/10.2337/db21-236-OR
Published: 01 June 2021
View article titled, 236-OR: Volagidemab, a Human Glucagon Receptor Antagonist, Improves Glycemic Control in Subjects with Type 1 Diabetes (T1D): A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Meeting Abstracts

344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia

SIMON R. HELLER, TADEJ BATTELINO, TIMOTHY S. BAILEY, RAMIN TEHRANCHI, LESLIE J. KLAFF, THOMAS PIEBER, ULRIKE HÖVELMANN, LEONA PLUM-MOERSCHEL, ANITA E. MELGAARD, RONNIE ARONSON, LINDA DIMEGLIO, THOMAS DANNE
Journal: Diabetes
Diabetes 2021;70(Supplement_1):344-P
https://doi.org/10.2337/db21-344-P
Published: 01 June 2021
View article titled, 344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia
Meeting Abstracts

345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups

TADEJ BATTELINO, TIMOTHY S. BAILEY, RAMIN TEHRANCHI, LESLIE J. KLAFF, THOMAS PIEBER, ULRIKE HÖVELMANN, LEONA PLUM-MOERSCHEL, ANITA E. MELGAARD, RONNIE ARONSON, LINDA DIMEGLIO, THOMAS DANNE
Journal: Diabetes
Diabetes 2021;70(Supplement_1):345-P
https://doi.org/10.2337/db21-345-P
Published: 01 June 2021
View article titled, 345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups
Meeting Abstracts

346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon

TADEJ BATTELINO, TIMOTHY S. BAILEY, RAMIN TEHRANCHI, LESLIE J. KLAFF, THOMAS PIEBER, ULRIKE HÖVELMANN, LEONA PLUM-MOERSCHEL, ANITA E. MELGAARD, RONNIE ARONSON, LINDA DIMEGLIO, THOMAS DANNE, ANNE L. PETERS
Journal: Diabetes
Diabetes 2021;70(Supplement_1):346-P
https://doi.org/10.2337/db21-346-P
Published: 01 June 2021
View article titled, 346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon
Meeting Abstracts

1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial

TIMOTHY S. BAILEY, JULIE WILLARD, LESLIE J. KLAFF, LENA S. LIST, ANITA E. MELGAARD, RAMIN TEHRANCHI
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1053-P
https://doi.org/10.2337/db20-1053-P
Published: 01 June 2020
View article titled, 1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial
Meeting Abstracts

232-OR: Long-Term Safety and Efficacy of Ultra-Rapid Lispro (URLi) in PRONTO-T1D

LESLIE J. KLAFF, JANG IK CHO, MARY A. DELLVA, NANETTE C. SCHLOOT, JANET TOBIAN, JUNNOSUKE MIURA, DOMINIK DAHL, JULIANA M. BUE-VALLESKEY
Journal: Diabetes
Diabetes 2020;69(Supplement_1):232-OR
https://doi.org/10.2337/db20-232-OR
Published: 01 June 2020
View article titled, 232-OR: Long-Term Safety and Efficacy of Ultra-Rapid Lispro (URLi) in PRONTO-T1D
Meeting Abstracts

144-OR: Ultra Rapid Lispro (URLi) Improves Postprandial Glucose (PPG) Control vs. Humalog (Lispro) in T1D: PRONTO-T1D Study

LESLIE J. KLAFF, DACHUANG CAO, MARY A. DELLVA, JANET TOBIAN, JUNNOSUKE MIURA, DOMINIK DAHL, JULIANA M. BUE-VALLESKEY
Journal: Diabetes
Diabetes 2019;68(Supplement_1):144-OR
https://doi.org/10.2337/db19-144-OR
Published: 01 June 2019
View article titled, 144-OR: Ultra Rapid Lispro (URLi) Improves Postprandial Glucose (PPG) Control vs. Humalog (Lispro) in T1D: PRONTO-T1D Study
Meeting Abstracts

171-LB: A Pilot Study to Evaluate the Utility of an Interconnected Diabetes Management Solution in People with T2D

LESLIE J. KLAFF, THOMAS MAIER, JAMES M. RICHARDSON, SCOTT PARDO
Journal: Diabetes
Diabetes 2019;68(Supplement_1):171-LB
https://doi.org/10.2337/db19-171-LB
Published: 01 June 2019
View article titled, 171-LB: A Pilot Study to Evaluate the Utility of an Interconnected Diabetes Management Solution in People with T2D
Meeting Abstracts

Improved Time-in-Range (TIR) on Continuous Glucose Monitor (CGM) with Technosphere Inhaled Insulin (TI) Compared with Insulin Aspart in T1D Patients—STAT Study

JANET K. SNELL-BERGEON, HALIS K. AKTURK, AMANDA REWERS, BRUCE W. BODE, LESLIE J. KLAFF, ANNE PETERS, TIMOTHY S. BAILEY, SATISH K. GARG
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1017-P
https://doi.org/10.2337/db18-1017-P
Published: 01 July 2018
View article titled, Improved Time-in-Range (TIR) on Continuous Glucose Monitor (CGM) with Technosphere Inhaled Insulin (TI) Compared with Insulin Aspart in T1D Patients—STAT Study
Meeting Abstracts

Improved Postprandial Blood Glucose (PPBG) Excursions with Technosphere Inhaled Insulin (TI) Compared with Aspart in T1D Patients—STAT Study

HALIS K. AKTURK, JANET K. SNELL-BERGEON, AMANDA REWERS, LESLIE J. KLAFF, ANNE PETERS, BRUCE W. BODE, TIMOTHY S. BAILEY, SATISH K. GARG
Journal: Diabetes
Diabetes 2018;67(Supplement_1):348-OR
https://doi.org/10.2337/db18-348-OR
Published: 01 July 2018
View article titled, Improved Postprandial Blood Glucose (PPBG) Excursions with Technosphere Inhaled Insulin (TI) Compared with Aspart in T1D Patients—STAT Study
Journal Articles

Lack of Systematically Found Insulin Autoantibodies in Spontaneously Diabetic BB Rats

Helle Markholst, Leslie J Klaff, Günter Klöppel, ÅKe Lernmark, John P Mordes, Jerry Palmer
Journal: Diabetes
Diabetes 1990;39(6):720–727
https://doi.org/10.2337/diab.39.6.720
Published: 01 June 1990
View article titled, Lack of Systematically Found Insulin Autoantibodies in Spontaneously Diabetic BB Rats
Open the PDF for Lack of Systematically Found Insulin Autoantibodies in Spontaneously Diabetic BB Rats in another window
Journal Articles

Nonprogression of Subclinical β-Cell Dysfunction Among First-Degree Relatives of IDDM Patients: 5-Yr Follow-Up of the Seattle Family Study

David K McCulloch, Leslie J Klaff, Steven E Kahn, Steven L Schoenfeld, Carla J Greenbaum, Richard S Mauseth, Edward A Benson, Gerald T Nepom, Linda Shewey, Jerry P Palmer
Journal: Diabetes
Diabetes 1990;39(5):549–556
https://doi.org/10.2337/diab.39.5.549
Published: 01 May 1990
View article titled, Nonprogression of Subclinical β-Cell Dysfunction Among First-Degree Relatives of IDDM Patients: 5-Yr Follow-Up of the Seattle Family Study
Open the PDF for Nonprogression of Subclinical β-Cell Dysfunction Among First-Degree Relatives of IDDM Patients: 5-Yr Follow-Up of the Seattle Family Study in another window
Journal Articles

β-Cell Function and Insulin Sensitivity in Nondiabetic HLA-identical Siblings of Insulin-Dependent Diabetics

Colin Johnston, Prema Raghu, David K McCulloch, James C Beard, W Ken Ward, Leslie J Klaff, Barbara McKnight, Richard N Bergman, Jerry P Palmer
Journal: Diabetes
Diabetes 1987;36(7):829–837
https://doi.org/10.2337/diab.36.7.829
Published: 01 July 1987
View article titled, β-Cell Function and Insulin Sensitivity in Nondiabetic HLA-identical Siblings of Insulin-Dependent Diabetics
Open the PDF for β-Cell Function and Insulin Sensitivity in Nondiabetic HLA-identical Siblings of Insulin-Dependent Diabetics in another window
Journal Articles

Pancreatic Somatostatin is a Mediator of Glucagon Inhibition by Hyperglycemia

Leslie J Klaff, Gerald J Taborsky, Jr
Journal: Diabetes
Diabetes 1987;36(5):592–596
https://doi.org/10.2337/diab.36.5.592
Published: 01 May 1987
View article titled, Pancreatic Somatostatin is a Mediator of Glucagon Inhibition by Hyperglycemia
Open the PDF for Pancreatic Somatostatin is a Mediator of Glucagon Inhibition by Hyperglycemia in another window